A new guideline from AAN offers recommendations on the use of behavioral, nutraceutical, and complementary and alternative medicine (CAM) for improving sleep disorders in children with ASD.
The stresses and sleep disturbances of shift work can lead to major mental health issues, as well as workplace challenges, including safety concerns and poor on-the-job performance.
The Food and Drug Administration (FDA) has approved updates to the prescribing information for Belsomra® (suvorexant; Merck) to include study findings for the treatment of insomnia in patients with mild to moderate Alzheimer disease.
Individuals most at risk for neurobehavioral performance impairment during sleep deprivation can be accurately identified by a visual psychomotor vigilance task.
Approximately 20% of women experienced an increase in sleep issues during the presurgery period, although for the majority of women sleep trajectories were generally stable pre- and postsurgery.
For persons with a previous diagnosis of generalized anxiety disorder (GAD), factors associated with being in complete mental health (CMH) include female gender, older age, being married, and reporting good to excellent physical health.
